Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc by (c) Belard et al., 2015
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/69249

Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Neonatal invasive disease due to Streptococcus agalactiae is life threatening and preventive strategies suitable for resource limited settings are urgently needed. Protective coverage of vaccine candidates based on capsular epitopes will relate to local epidemiology of S. agalactiae serotypes and successful management of critical infections depends on timely therapy with effective antibiotics. This is the first report on serotype distribution and antimicrobial susceptibility of S. agalactiae in pregnant women from a Central African region. Serotypes V, III, and Ib accounted for 88/109 (81%) serotypes and all isolates were susceptible to penicillin and clindamycin while 13% showed intermediate susceptibility to erythromycin.

Citation

Citation

BELARD, Sabine, et al. Streptococcus agalactiae Serotype Distribution and Antimicrobial
                Susceptibility in Pregnant Women in Gabon, Central Africa. Scientific Reports. 2015. Vol. 5, pags. 17281. ISSN 2045-2322. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/69249

Export metadata

JSON - METS

Share record